查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
2014371

脐带血库服务市场：2026-2032年全球市场预测（按服务类型、处理方法、交付方式、储存期限、细胞类型、应用和最终用户划分）

Cord Blood Banking Services Market by Service Type, Processing Method, Delivery Mode, Storage Duration, Cell Type, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，脐带血库服务市场价值将达到 416.9 亿美元，到 2026 年将成长至 468.1 亿美元，到 2032 年将达到 1,008.3 亿美元，复合年增长率为 13.44%。

主要市场统计数据
基准年 2025 416.9亿美元
预计年份：2026年 468.1亿美元
预测年份 2032 1008.3亿美元
复合年增长率 (%) 13.44%

本文重点介绍脐带血库在临床创新、营运复杂性、监管变化和相关人员决策架构下的发展。

脐带血库处于临床创新、以病人为中心的照护和复杂运作结构交汇的独特位置。过去十年，干细胞科学和转化医学的进步提高了人们对脐带血疗法的期望，而采集、处理和冷冻保存技术的改进则为临床医生和家庭提供了更多实际选择。同时，不断发展的法规结构以及对品质和可追溯性日益增长的需求，也重新定义了整个产业的营运标准。

分析正在重塑脐带血服务的采集、处理、储存和管治的变革性技术、临床和监管变化。

脐带血库产业正经历着变革性的转变，这主要得益于技术的成熟、临床模式的转变以及监管环境的日益完善。技术进步缩短了处理时间，提高了细胞活力指标，从而促进了新治疗方法的探索，并扩大了临床适应症的研究范围。同时，用于供体追踪、知情同意管理和生物库库存管理的数位化平台的整合，提高了透明度和营运效率，进而提升了可追溯性和品质保证水准。

仔细评估 2025 年美国关税政策变化将如何影响整个脐带血产业的采购、物流和风险管理趋势。

2025年美国关税政策的变化为全球医疗用品供应链和生物材料跨境运输带来了新的复杂性。这些措施正直接影响脐带血业务所需的耗材、冷冻保存设备和诊断试剂供应商，以及用于研发和临床的生物检体的国际运输。事实上，关税导致的成本调整正在改变筹资策略，促使企业重新评估供应商多元化，并尽可能与国内製造商建立更紧密的采购关係。

以细分为导向的全面观点，将服务模式、临床应用、最终用户、处理方法和细胞产品类型与实际操作选择相结合。

在脐带血库领域，对细分市场的深入了解对于制定有针对性的服务提案和临床路径至关重要。根据服务类型，脐带血库的营运模式分为混合型、私人型和公立型，每种模式都有其独特的商业性逻辑、知情同意框架和相关人员关係，这些因素会影响註册数量、定价结构和合作机会。根据应用领域，市场涵盖再生医学、研究和移植。再生医学在心血管、肌肉骨骼和神经系统疾病方面的需求不断增长，这需要特定的处理标准和细胞富集技术。研究应用分为学术研究和商业研究；学术研究致力于基础发现，而商业项目则着重于产品开发和转化应用。移植应用包括血液系统疾病、免疫系统疾病和肿瘤疾病，这些疾病的储存和取得均受临床方案和适用性要求的约束。

深入了解监管多样性、医疗保健基础设施和本地製造能力如何影响脐带血在全球主要市场的引入，包括区域差异。

区域趋势在塑造脐带血服务的监管预期、合作伙伴生态系统和推广路径方面发挥着至关重要的作用。在美洲，国家监管机构和保险公司在建立临床应用和推广路径方面扮演核心角色，大规模医疗保健网路通常是与临床医生合作以及进行病患宣传宣传活动的主要管道。此外，美洲拥有强大的医疗用品国内生产能力，这会影响筹资策略和业务永续营运计画。

评估市场参与企业之间的竞争与合作行为：重点在于策略投资领域、伙伴关係模式与营运差异化因素。

脐带血领域的竞争动态取决于服务品质、临床伙伴关係、技术能力和可靠性等因素的综合作用。领先机构已投资建置端对端可追溯系统、严格的品管系统以及专有的处理技术，以提升储存脐带血的临床效用。与大学附属医院、临床研究网络和医疗设备製造商建立策略合作伙伴关係，是展示实际疗效和确保转诊途径的关键机制。

为实现永续成长，提出切实可行的策略建议，包括整合供应链韧性、数位化、临床证据产生和伙伴关係主导的能力建构。

产业领导企业应优先考虑那些既能确保短期营运稳健性，又能兼顾长期临床和商业性定位的投资。首先，应透过多元化关键供应商、确保低温设备和耗材的冗余，以及实施反映新贸易情势的合约保障措施，来增强供应链的韧性。这些措施将有助于降低采购衝击带来的风险，并为策略性采购决策创造更多空间。

我们采用透明的混合方法研究方法，结合对关键相关人员的访谈、二手文献的整合和系统的检验，获得了可操作的见解。

本分析的调查方法融合了质性访谈、二手文献和系统性的资料检验，以确保研究结果的稳健性和相关性。主要研究包括对临床负责人、营运经理和监管专家进行结构化访谈，以了解实际应用中的限制因素、新兴用例和推广障碍。这些访谈内容经过主题编码，以确保所获得的营运洞察反映的是真实情况而非理论概念。

将技术进步、卓越营运和证据生成与脐带血服务的未来临床和商业性可行性联繫起来，得出简洁的结论。

总之，脐带血库正处于一个转折点，技术进步、临床应用的变化以及监管期望的演变在此交汇，有可能重新定义其价值提案。那些能够将严格的品管、有针对性的临床证据产生以及灵活的供应链策略相结合的机构，将更有能力将科学潜力转化为可持续的临床效用。不断变化的收费系统和贸易环境凸显了韧性和在地采购选项的重要性，而数位平台的进步则促进了家庭、临床医生和生物库之间更顺畅的合作。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 市场进入策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章：脐带血库服务市场：依服务类型划分

  • 私人脐带血库
  • 公共脐带血库

第九章 依处理方法分類的脐带血库服务市场

  • 单核细胞的分离
  • MSC富集
  • 产能下降

第十章：脐带血库服务市场：依交付方式划分

  • 异地收集
  • 现场收集

第十一章 依储存期分類的脐带血库服务市场

  • 长期储存
  • 短期储存

第十二章 脐带血库服务市场（依细胞类型划分）

  • CD34阳性细胞
  • 有核细胞总数

第十三章 脐带血库服务市场：依应用领域划分

  • 再生医学
    • 心血管系统
    • 肌肉骨骼系统
    • 神经系统
  • 调查
    • 学术的
    • 商业的
  • 移植
    • 血液疾病
    • 免疫疾病
    • 肿瘤性疾病

第十四章 脐带血库服务市场：依最终用户划分

  • 诊所
  • 医院
  • 研究机构

第十五章：脐带血库服务市场：依地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十六章 脐带血库服务市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十七章 脐带血库服务市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十八章：美国脐带血库服务市场

第十九章：中国脐带血库服务市场

第20章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • AlphaCord, LLC
  • Americord Registry, LLC
  • Cells4Life Limited
  • China Cord Blood Corporation
  • Cord Blood Registry, LLC
  • Cord for Life, LLC
  • Cordlife Group Limited
  • Cryo-Cell International, Inc.
  • Cryoholdco LLC
  • Cryoviva Healthcare Private Limited
  • CSG-BIO, Inc.
  • FamiCord SA
  • Life Sciences
  • LifeCell International Private Limited
  • Medipost Co., Ltd.
  • StemCyte, Inc.
  • Vcanbio Cell & Gene Engineering Corp.
  • ViaCord, LLC
  • Vita 34 AG
Product Code: MRR-4311CE1A33C4

The Cord Blood Banking Services Market was valued at USD 41.69 billion in 2025 and is projected to grow to USD 46.81 billion in 2026, with a CAGR of 13.44%, reaching USD 100.83 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 41.69 billion
Estimated Year [2026] USD 46.81 billion
Forecast Year [2032] USD 100.83 billion
CAGR (%) 13.44%

A focused introduction that situates cord blood banking within clinical innovation, operational complexity, regulatory evolution, and stakeholder decision frameworks

Cord blood banking occupies a distinctive intersection of clinical innovation, patient-centric care, and complex operational delivery. Over the past decade, advances in stem cell science and translational medicine have strengthened the therapeutic promise of cord blood-derived products, while improvements in collection, processing, and cryostorage have expanded practical options for clinicians and families alike. At the same time, evolving regulatory frameworks and heightened expectations around quality and traceability have redefined operational benchmarks across the sector.

This introduction situates the reader within the prevailing ecosystem by clarifying the principal service models, clinical and research applications, and typical end-user interactions that shape decision-making. It foregrounds the interplay between scientific opportunity and logistical realities, emphasizing how governance, reimbursement dynamics, and institutional partnerships influence adoption pathways. With a focus on actionable context rather than speculative optimism, the narrative establishes the parameters for subsequent analysis and underlines the core drivers that stakeholders must monitor to maintain resilience and agility in a rapidly maturing market.

An analysis of the transformative technological, clinical, and regulatory shifts reshaping how cord blood services are collected, processed, stored, and governed

The cord blood banking landscape is experiencing transformative shifts driven by technological maturation, shifting clinical paradigms, and a more sophisticated regulatory environment. Technological advances have reduced processing time and improved cell viability metrics, enabling new therapeutic explorations and expanding the range of clinical indications under investigation. Concurrently, the integration of digital platforms for donor tracking, consent management, and biobank inventory control is improving transparency and operational efficiency, which in turn supports higher standards of traceability and quality assurance.

Clinical paradigms are also changing as regenerative medicine applications and cell therapy research increasingly intersect with traditional transplantation pathways. This convergence broadens the potential utility of stored cord blood units while requiring biobanks to refine their processing and storage protocols to meet diverse downstream needs. Regulatory authorities are responding with more defined guidance on Good Tissue Practice, data governance, and cross-border logistics, prompting providers to invest in compliance systems and standardized documentation. Taken together, these shifts are fostering a more professionalized market environment where strategic partnerships, interoperability, and demonstrable outcomes are becoming the primary differentiators among providers.

A measured assessment of how United States tariff policy changes in 2025 have altered procurement, logistics, and risk management dynamics across cord blood operations

Tariff policy developments in the United States in 2025 introduced a new layer of complexity into global supply chains for medical goods and cross-border biological material movement. These measures have immediate implications for suppliers of consumables, cryopreservation equipment, and diagnostic reagents that support cord blood operations, as well as for international transfers of biological samples for research and clinical use. In practice, tariff-driven cost adjustments have altered procurement strategies, prompting a reassessment of supplier diversification and incentivizing closer sourcing relationships with domestic manufacturers where feasible.

Operational consequences extend beyond direct cost impacts to include shifts in logistics planning, customs clearance processes, and contract terms with international partners. Organizations that previously relied on lean global supply chains are re-evaluating inventory policies and buffer stocks to protect continuity of services. In addition, tariffs have encouraged some stakeholders to accelerate onshoring of critical manufacturing and to renegotiate service level agreements that better reflect current trade risks. From a strategic perspective, the tariff environment underscores the importance of scenario planning, supplier risk assessment, and adaptive procurement frameworks that can mitigate disruption while maintaining clinical and research continuity.

A comprehensive segmentation-driven perspective that aligns service models, clinical applications, end users, processing methods, and cellular product types to practical operating choices

Segment-level understanding is pivotal to crafting targeted service propositions and clinical pathways in cord blood banking. Based on Service Type, providers operate across hybrid, private, and public models, each presenting distinct commercial logics, consent frameworks, and stakeholder relationships that influence enrollment, pricing structures, and partnership opportunities. Based on Application, the market spans regenerative medicine, research, and transplantation. Regenerative medicine demand is being developed across cardiovascular, musculoskeletal, and neurological indications, requiring specific processing standards and cell enrichment approaches. Research applications are divided between academic and commercial research, with academic work driving fundamental discovery and commercial programs focused on product development and translational pipelines. Transplantation use cases include hematological disorders, immunological disorders, and oncological disorders, where clinical protocols and compatibility requirements dictate storage and retrieval practices.

Based on End User, activities are organized around clinics, hospitals, and research institutes, each demanding different engagement models, service level agreements, and reporting requirements. Based on Delivery Mode, collection strategies vary between off site collection and on site collection, affecting logistics, parental engagement, and chain-of-custody management. Based on Processing Method, laboratories deploy mononuclear cell isolation, MSC enrichment, and volume reduction techniques to prepare units for intended applications, and these methods have direct implications for yield, product specification, and downstream usability. Based on Storage Duration, facilities manage both long term storage and short term storage needs that reflect clinical readiness and research timelines. Based on Cell Type, cord blood services commonly differentiate handling for CD34 positive cells versus total nucleated cells, with processing, quality control, and release criteria aligned to the intended clinical or investigational use. Together, these segmentation lenses provide a comprehensive map for tailoring operational design, R&D prioritization, and market access activities.

Regionally nuanced insights into how regulatory diversity, healthcare infrastructure, and local manufacturing capacity influence cord blood adoption across major global markets

Regional dynamics play a critical role in shaping regulatory expectations, partner ecosystems, and adoption pathways for cord blood services. In the Americas, national regulatory agencies and payers are central to establishing pathways for clinical translation and adoption, and large healthcare networks often provide the primary points of clinician engagement and patient awareness campaigns. The Americas region also has notable capacity for domestic manufacturing of medical supplies, which influences procurement strategies and resilience planning.

In Europe, Middle East & Africa, regulatory heterogeneity and varying healthcare infrastructures require flexible commercialization approaches that emphasize compliance harmonization, localized partnerships, and tailored pricing strategies. Cross-border collaboration within this region often depends on mutual recognition frameworks and data transfer agreements that support research consortia and multicenter trials. Asia-Pacific presents a mix of rapid clinical adoption in some markets and nascent research development in others, with strong private-sector investment and growing biomanufacturing capabilities. Each region demonstrates unique strengths and constraints that influence decisions about where to prioritize clinical programs, where to invest in infrastructure, and how to design go-to-market models that accommodate local regulatory and reimbursement realities.

An appraisal of competitive and collaborative behaviours among market participants that highlights strategic investment areas, partnership models, and operational differentiators

Competitive dynamics in the cord blood arena are defined by a combination of service quality, clinical partnerships, technological capability, and reputational trust. Leading organizations have invested in end-to-end traceability systems, rigorous quality management, and proprietary processing techniques that enhance the clinical utility of stored units. Strategic collaborations with academic medical centers, clinical research networks, and device manufacturers have become important mechanisms for demonstrating real-world outcomes and securing referral pathways.

Mergers, partnerships, and vertical integration are observable strategies among market participants seeking to secure supply chains, broaden service offerings, and accelerate clinical validation. Investment in digital capabilities-covering consent management, cloud-based inventory control, and telemedicine-enabled client engagement-has emerged as a differentiator that improves customer experience and operational transparency. At the same time, smaller and specialized providers distinguish themselves through niche clinical focus, bespoke processing protocols, or deep relationships with regional healthcare systems. For stakeholders evaluating potential partners, the emphasis should be on validated quality systems, clinical evidence generation, and an ability to scale services in a compliant manner while preserving patient-centric care models.

Actionable strategic recommendations that blend supply chain resilience, digital modernization, clinical evidence generation, and partnership-driven capacity building for sustained growth

Industry leaders should prioritize investments that balance near-term operational robustness with long-term clinical and commercial positioning. First, strengthen supply chain resilience by diversifying critical suppliers, establishing redundancy for cryogenic equipment and consumables, and implementing contractual protections that reflect new trade realities. Such actions reduce exposure to procurement shocks and provide breathing room for strategic sourcing decisions.

Second, accelerate digital transformation to improve consent capture, chain-of-custody visibility, and client communication. Digital systems that integrate with electronic health records and support secure data exchange will streamline enrollment and retrieval workflows, enhancing clinician and patient satisfaction. Third, invest in targeted clinical evidence generation by sponsoring rigorous trials and observational studies across prioritized regenerative and transplantation indications; outcomes data will be decisive in payer discussions and clinical adoption. Fourth, pursue regulatory alignment and proactive compliance by engaging with authorities early, harmonizing quality systems to international standards, and documenting end-to-end traceability. Finally, cultivate strategic partnerships across academic centers, device suppliers, and logistics providers to create vertically integrated pathways from collection to therapeutic application. Collectively, these recommendations position organizations to capture emerging opportunities while mitigating operational and regulatory risks.

A transparent mixed-methods research approach combining primary stakeholder interviews, secondary literature synthesis, and systematic validation to produce actionable findings

The research methodology underpinning this analysis integrates primary qualitative interviews, secondary literature synthesis, and systematic data validation to ensure robustness and relevance. Primary engagement included structured interviews with clinical leaders, operational managers, and regulatory specialists to capture real-world constraints, emerging use cases, and adoption barriers. These conversations informed thematic coding and ensured that operational insights reflected pragmatic realities rather than theoretical constructs.

Secondary research encompassed review of peer-reviewed literature, regulatory guidance documents, technical white papers, and vendor specifications to triangulate technology trends and compliance expectations. Findings from primary and secondary sources were reconciled through cross-validation exercises, where discrepant inputs were resolved by returning to subject-matter experts or by examining recent regulatory announcements for clarification. The approach prioritized transparency in assumptions, reproducibility of analytic steps, and traceable linkage between evidence and implication. Ethical considerations and data privacy were embedded throughout the methodology, with attention to anonymization where interviewees provided proprietary or sensitive operational details. This mixed-methods approach supports a balanced, evidence-driven perspective that is actionable for commercial, clinical, and policy audiences.

A concise concluding synthesis that links technological progress, operational excellence, and evidence generation to the future clinical and commercial viability of cord blood services

In conclusion, cord blood banking stands at an inflection point where technological progress, shifting clinical applications, and evolving regulatory expectations are converging to redefine value propositions. Organizations that combine rigorous quality management, targeted clinical evidence generation, and adaptive supply chain strategies will be best positioned to translate scientific potential into sustained clinical utility. The evolving tariff and trade environment highlights the importance of resilience and local sourcing options, while advances in digital platforms are enabling more seamless interactions between families, clinicians, and biobanks.

Strategic clarity around segmentation-service model, application focus, end-user engagement, delivery mode, processing method, storage duration, and cell type-will enable providers to align capabilities to market needs and to pursue partnerships that amplify clinical impact. Ultimately, pragmatic investment in operational excellence, regulatory alignment, and evidence-based clinical programs will generate the credibility and performance required to realize the broader promise of cord blood-derived therapies and research initiatives.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Cord Blood Banking Services Market, by Service Type

  • 8.1. Private Cord Blood Banks
  • 8.2. Public Cord Blood Banks

9. Cord Blood Banking Services Market, by Processing Method

  • 9.1. Mononuclear Cell Isolation
  • 9.2. MSC Enrichment
  • 9.3. Volume Reduction

10. Cord Blood Banking Services Market, by Delivery Mode

  • 10.1. Off Site Collection
  • 10.2. On Site Collection

11. Cord Blood Banking Services Market, by Storage Duration

  • 11.1. Long Term Storage
  • 11.2. Short Term Storage

12. Cord Blood Banking Services Market, by Cell Type

  • 12.1. CD34 Positive Cells
  • 12.2. Total Nucleated Cells

13. Cord Blood Banking Services Market, by Application

  • 13.1. Regenerative Medicine
    • 13.1.1. Cardiovascular
    • 13.1.2. Musculoskeletal
    • 13.1.3. Neurological
  • 13.2. Research
    • 13.2.1. Academic
    • 13.2.2. Commercial
  • 13.3. Transplantation
    • 13.3.1. Hematological Disorders
    • 13.3.2. Immunological Disorders
    • 13.3.3. Oncological Disorders

14. Cord Blood Banking Services Market, by End User

  • 14.1. Clinics
  • 14.2. Hospitals
  • 14.3. Research Institutes

15. Cord Blood Banking Services Market, by Region

  • 15.1. Americas
    • 15.1.1. North America
    • 15.1.2. Latin America
  • 15.2. Europe, Middle East & Africa
    • 15.2.1. Europe
    • 15.2.2. Middle East
    • 15.2.3. Africa
  • 15.3. Asia-Pacific

16. Cord Blood Banking Services Market, by Group

  • 16.1. ASEAN
  • 16.2. GCC
  • 16.3. European Union
  • 16.4. BRICS
  • 16.5. G7
  • 16.6. NATO

17. Cord Blood Banking Services Market, by Country

  • 17.1. United States
  • 17.2. Canada
  • 17.3. Mexico
  • 17.4. Brazil
  • 17.5. United Kingdom
  • 17.6. Germany
  • 17.7. France
  • 17.8. Russia
  • 17.9. Italy
  • 17.10. Spain
  • 17.11. China
  • 17.12. India
  • 17.13. Japan
  • 17.14. Australia
  • 17.15. South Korea

18. United States Cord Blood Banking Services Market

19. China Cord Blood Banking Services Market

20. Competitive Landscape

  • 20.1. Market Concentration Analysis, 2025
    • 20.1.1. Concentration Ratio (CR)
    • 20.1.2. Herfindahl Hirschman Index (HHI)
  • 20.2. Recent Developments & Impact Analysis, 2025
  • 20.3. Product Portfolio Analysis, 2025
  • 20.4. Benchmarking Analysis, 2025
  • 20.5. AlphaCord, LLC
  • 20.6. Americord Registry, LLC
  • 20.7. Cells4Life Limited
  • 20.8. China Cord Blood Corporation
  • 20.9. Cord Blood Registry, LLC
  • 20.10. Cord for Life, LLC
  • 20.11. Cordlife Group Limited
  • 20.12. Cryo-Cell International, Inc.
  • 20.13. Cryoholdco LLC
  • 20.14. Cryoviva Healthcare Private Limited
  • 20.15. CSG-BIO, Inc.
  • 20.16. FamiCord S.A.
  • 20.17. Life Sciences
  • 20.18. LifeCell International Private Limited
  • 20.19. Medipost Co., Ltd.
  • 20.20. StemCyte, Inc.
  • 20.21. Vcanbio Cell & Gene Engineering Corp.
  • 20.22. ViaCord, LLC
  • 20.23. Vita 34 AG

LIST OF FIGURES

  • FIGURE 1. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL CORD BLOOD BANKING SERVICES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL CORD BLOOD BANKING SERVICES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY SERVICE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY PROCESSING METHOD, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY DELIVERY MODE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY STORAGE DURATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY CELL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. UNITED STATES CORD BLOOD BANKING SERVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 15. CHINA CORD BLOOD BANKING SERVICES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY PRIVATE CORD BLOOD BANKS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY PRIVATE CORD BLOOD BANKS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY PRIVATE CORD BLOOD BANKS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY PUBLIC CORD BLOOD BANKS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY PUBLIC CORD BLOOD BANKS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY PUBLIC CORD BLOOD BANKS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY PROCESSING METHOD, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY MONONUCLEAR CELL ISOLATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY MONONUCLEAR CELL ISOLATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY MONONUCLEAR CELL ISOLATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY MSC ENRICHMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY MSC ENRICHMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY MSC ENRICHMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY VOLUME REDUCTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY VOLUME REDUCTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY VOLUME REDUCTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY OFF SITE COLLECTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY OFF SITE COLLECTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY OFF SITE COLLECTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY ON SITE COLLECTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY ON SITE COLLECTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY ON SITE COLLECTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY STORAGE DURATION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY LONG TERM STORAGE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY LONG TERM STORAGE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY LONG TERM STORAGE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY SHORT TERM STORAGE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY SHORT TERM STORAGE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY SHORT TERM STORAGE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY CELL TYPE, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY CD34 POSITIVE CELLS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY CD34 POSITIVE CELLS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY CD34 POSITIVE CELLS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY TOTAL NUCLEATED CELLS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY TOTAL NUCLEATED CELLS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY TOTAL NUCLEATED CELLS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY REGENERATIVE MEDICINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY REGENERATIVE MEDICINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY REGENERATIVE MEDICINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY CARDIOVASCULAR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY CARDIOVASCULAR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY MUSCULOSKELETAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY MUSCULOSKELETAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY MUSCULOSKELETAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY NEUROLOGICAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY NEUROLOGICAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY NEUROLOGICAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY RESEARCH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY RESEARCH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY RESEARCH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY ACADEMIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY ACADEMIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY ACADEMIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY COMMERCIAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY COMMERCIAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY COMMERCIAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY TRANSPLANTATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY TRANSPLANTATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY TRANSPLANTATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY TRANSPLANTATION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY HEMATOLOGICAL DISORDERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY HEMATOLOGICAL DISORDERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY HEMATOLOGICAL DISORDERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY IMMUNOLOGICAL DISORDERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY IMMUNOLOGICAL DISORDERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY IMMUNOLOGICAL DISORDERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY ONCOLOGICAL DISORDERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY ONCOLOGICAL DISORDERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY ONCOLOGICAL DISORDERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. AMERICAS CORD BLOOD BANKING SERVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 89. AMERICAS CORD BLOOD BANKING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 90. AMERICAS CORD BLOOD BANKING SERVICES MARKET SIZE, BY PROCESSING METHOD, 2018-2032 (USD MILLION)
  • TABLE 91. AMERICAS CORD BLOOD BANKING SERVICES MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 92. AMERICAS CORD BLOOD BANKING SERVICES MARKET SIZE, BY STORAGE DURATION, 2018-2032 (USD MILLION)
  • TABLE 93. AMERICAS CORD BLOOD BANKING SERVICES MARKET SIZE, BY CELL TYPE, 2018-2032 (USD MILLION)
  • TABLE 94. AMERICAS CORD BLOOD BANKING SERVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 95. AMERICAS CORD BLOOD BANKING SERVICES MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2032 (USD MILLION)
  • TABLE 96. AMERICAS CORD BLOOD BANKING SERVICES MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 97. AMERICAS CORD BLOOD BANKING SERVICES MARKET SIZE, BY TRANSPLANTATION, 2018-2032 (USD MILLION)
  • TABLE 98. AMERICAS CORD BLOOD BANKING SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 99. NORTH AMERICA CORD BLOOD BANKING SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. NORTH AMERICA CORD BLOOD BANKING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 101. NORTH AMERICA CORD BLOOD BANKING SERVICES MARKET SIZE, BY PROCESSING METHOD, 2018-2032 (USD MILLION)
  • TABLE 102. NORTH AMERICA CORD BLOOD BANKING SERVICES MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 103. NORTH AMERICA CORD BLOOD BANKING SERVICES MARKET SIZE, BY STORAGE DURATION, 2018-2032 (USD MILLION)
  • TABLE 104. NORTH AMERICA CORD BLOOD BANKING SERVICES MARKET SIZE, BY CELL TYPE, 2018-2032 (USD MILLION)
  • TABLE 105. NORTH AMERICA CORD BLOOD BANKING SERVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 106. NORTH AMERICA CORD BLOOD BANKING SERVICES MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2032 (USD MILLION)
  • TABLE 107. NORTH AMERICA CORD BLOOD BANKING SERVICES MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 108. NORTH AMERICA CORD BLOOD BANKING SERVICES MARKET SIZE, BY TRANSPLANTATION, 2018-2032 (USD MILLION)
  • TABLE 109. NORTH AMERICA CORD BLOOD BANKING SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 110. LATIN AMERICA CORD BLOOD BANKING SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. LATIN AMERICA CORD BLOOD BANKING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 112. LATIN AMERICA CORD BLOOD BANKING SERVICES MARKET SIZE, BY PROCESSING METHOD, 2018-2032 (USD MILLION)
  • TABLE 113. LATIN AMERICA CORD BLOOD BANKING SERVICES MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 114. LATIN AMERICA CORD BLOOD BANKING SERVICES MARKET SIZE, BY STORAGE DURATION, 2018-2032 (USD MILLION)
  • TABLE 115. LATIN AMERICA CORD BLOOD BANKING SERVICES MARKET SIZE, BY CELL TYPE, 2018-2032 (USD MILLION)
  • TABLE 116. LATIN AMERICA CORD BLOOD BANKING SERVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 117. LATIN AMERICA CORD BLOOD BANKING SERVICES MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2032 (USD MILLION)
  • TABLE 118. LATIN AMERICA CORD BLOOD BANKING SERVICES MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 119. LATIN AMERICA CORD BLOOD BANKING SERVICES MARKET SIZE, BY TRANSPLANTATION, 2018-2032 (USD MILLION)
  • TABLE 120. LATIN AMERICA CORD BLOOD BANKING SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 121. EUROPE, MIDDLE EAST & AFRICA CORD BLOOD BANKING SERVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 122. EUROPE, MIDDLE EAST & AFRICA CORD BLOOD BANKING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 123. EUROPE, MIDDLE EAST & AFRICA CORD BLOOD BANKING SERVICES MARKET SIZE, BY PROCESSING METHOD, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA CORD BLOOD BANKING SERVICES MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA CORD BLOOD BANKING SERVICES MARKET SIZE, BY STORAGE DURATION, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA CORD BLOOD BANKING SERVICES MARKET SIZE, BY CELL TYPE, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA CORD BLOOD BANKING SERVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA CORD BLOOD BANKING SERVICES MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA CORD BLOOD BANKING SERVICES MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA CORD BLOOD BANKING SERVICES MARKET SIZE, BY TRANSPLANTATION, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA CORD BLOOD BANKING SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPE CORD BLOOD BANKING SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE CORD BLOOD BANKING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPE CORD BLOOD BANKING SERVICES MARKET SIZE, BY PROCESSING METHOD, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPE CORD BLOOD BANKING SERVICES MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPE CORD BLOOD BANKING SERVICES MARKET SIZE, BY STORAGE DURATION, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPE CORD BLOOD BANKING SERVICES MARKET SIZE, BY CELL TYPE, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPE CORD BLOOD BANKING SERVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPE CORD BLOOD BANKING SERVICES MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPE CORD BLOOD BANKING SERVICES MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPE CORD BLOOD BANKING SERVICES MARKET SIZE, BY TRANSPLANTATION, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPE CORD BLOOD BANKING SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 143. MIDDLE EAST CORD BLOOD BANKING SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 144. MIDDLE EAST CORD BLOOD BANKING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 145. MIDDLE EAST CORD BLOOD BANKING SERVICES MARKET SIZE, BY PROCESSING METHOD, 2018-2032 (USD MILLION)
  • TABLE 146. MIDDLE EAST CORD BLOOD BANKING SERVICES MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 147. MIDDLE EAST CORD BLOOD BANKING SERVICES MARKET SIZE, BY STORAGE DURATION, 2018-2032 (USD MILLION)
  • TABLE 148. MIDDLE EAST CORD BLOOD BANKING SERVICES MARKET SIZE, BY CELL TYPE, 2018-2032 (USD MILLION)
  • TABLE 149. MIDDLE EAST CORD BLOOD BANKING SERVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 150. MIDDLE EAST CORD BLOOD BANKING SERVICES MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2032 (USD MILLION)
  • TABLE 151. MIDDLE EAST CORD BLOOD BANKING SERVICES MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 152. MIDDLE EAST CORD BLOOD BANKING SERVICES MARKET SIZE, BY TRANSPLANTATION, 2018-2032 (USD MILLION)
  • TABLE 153. MIDDLE EAST CORD BLOOD BANKING SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 154. AFRICA CORD BLOOD BANKING SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 155. AFRICA CORD BLOOD BANKING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 156. AFRICA CORD BLOOD BANKING SERVICES MARKET SIZE, BY PROCESSING METHOD, 2018-2032 (USD MILLION)
  • TABLE 157. AFRICA CORD BLOOD BANKING SERVICES MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 158. AFRICA CORD BLOOD BANKING SERVICES MARKET SIZE, BY STORAGE DURATION, 2018-2032 (USD MILLION)
  • TABLE 159. AFRICA CORD BLOOD BANKING SERVICES MARKET SIZE, BY CELL TYPE, 2018-2032 (USD MILLION)
  • TABLE 160. AFRICA CORD BLOOD BANKING SERVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 161. AFRICA CORD BLOOD BANKING SERVICES MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2032 (USD MILLION)
  • TABLE 162. AFRICA CORD BLOOD BANKING SERVICES MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 163. AFRICA CORD BLOOD BANKING SERVICES MARKET SIZE, BY TRANSPLANTATION, 2018-2032 (USD MILLION)
  • TABLE 164. AFRICA CORD BLOOD BANKING SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 165. ASIA-PACIFIC CORD BLOOD BANKING SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 166. ASIA-PACIFIC CORD BLOOD BANKING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 167. ASIA-PACIFIC CORD BLOOD BANKING SERVICES MARKET SIZE, BY PROCESSING METHOD, 2018-2032 (USD MILLION)
  • TABLE 168. ASIA-PACIFIC CORD BLOOD BANKING SERVICES MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 169. ASIA-PACIFIC CORD BLOOD BANKING SERVICES MARKET SIZE, BY STORAGE DURATION, 2018-2032 (USD MILLION)
  • TABLE 170. ASIA-PACIFIC CORD BLOOD BANKING SERVICES MARKET SIZE, BY CELL TYPE, 2018-2032 (USD MILLION)
  • TABLE 171. ASIA-PACIFIC CORD BLOOD BANKING SERVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 172. ASIA-PACIFIC CORD BLOOD BANKING SERVICES MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2032 (USD MILLION)
  • TABLE 173. ASIA-PACIFIC CORD BLOOD BANKING SERVICES MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 174. ASIA-PACIFIC CORD BLOOD BANKING SERVICES MARKET SIZE, BY TRANSPLANTATION, 2018-2032 (USD MILLION)
  • TABLE 175. ASIA-PACIFIC CORD BLOOD BANKING SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 176. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 177. ASEAN CORD BLOOD BANKING SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 178. ASEAN CORD BLOOD BANKING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 179. ASEAN CORD BLOOD BANKING SERVICES MARKET SIZE, BY PROCESSING METHOD, 2018-2032 (USD MILLION)
  • TABLE 180. ASEAN CORD BLOOD BANKING SERVICES MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 181. ASEAN CORD BLOOD BANKING SERVICES MARKET SIZE, BY STORAGE DURATION, 2018-2032 (USD MILLION)
  • TABLE 182. ASEAN CORD BLOOD BANKING SERVICES MARKET SIZE, BY CELL TYPE, 2018-2032 (USD MILLION)
  • TABLE 183. ASEAN CORD BLOOD BANKING SERVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 184. ASEAN CORD BLOOD BANKING SERVICES MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2032 (USD MILLION)
  • TABLE 185. ASEAN CORD BLOOD BANKING SERVICES MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 186. ASEAN CORD BLOOD BANKING SERVICES MARKET SIZE, BY TRANSPLANTATION, 2018-2032 (USD MILLION)
  • TABLE 187. ASEAN CORD BLOOD BANKING SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 188. GCC CORD BLOOD BANKING SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 189. GCC CORD BLOOD BANKING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 190. GCC CORD BLOOD BANKING SERVICES MARKET SIZE, BY PROCESSING METHOD, 2018-2032 (USD MILLION)
  • TABLE 191. GCC CORD BLOOD BANKING SERVICES MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 192. GCC CORD BLOOD BANKING SERVICES MARKET SIZE, BY STORAGE DURATION, 2018-2032 (USD MILLION)
  • TABLE 193. GCC CORD BLOOD BANKING SERVICES MARKET SIZE, BY CELL TYPE, 2018-2032 (USD MILLION)
  • TABLE 194. GCC CORD BLOOD BANKING SERVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 195. GCC CORD BLOOD BANKING SERVICES MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2032 (USD MILLION)
  • TABLE 196. GCC CORD BLOOD BANKING SERVICES MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 197. GCC CORD BLOOD BANKING SERVICES MARKET SIZE, BY TRANSPLANTATION, 2018-2032 (USD MILLION)
  • TABLE 198. GCC CORD BLOOD BANKING SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 199. EUROPEAN UNION CORD BLOOD BANKING SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 200. EUROPEAN UNION CORD BLOOD BANKING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 201. EUROPEAN UNION CORD BLOOD BANKING SERVICES MARKET SIZE, BY PROCESSING METHOD, 2018-2032 (USD MILLION)
  • TABLE 202. EUROPEAN UNION CORD BLOOD BANKING SERVICES MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 203. EUROPEAN UNION CORD BLOOD BANKING SERVICES MARKET SIZE, BY STORAGE DURATION, 2018-2032 (USD MILLION)
  • TABLE 204. EUROPEAN UNION CORD BLOOD BANKING SERVICES MARKET SIZE, BY CELL TYPE, 2018-2032 (USD MILLION)
  • TABLE 205. EUROPEAN UNION CORD BLOOD BANKING SERVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 206. EUROPEAN UNION CORD BLOOD BANKING SERVICES MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2032 (USD MILLION)
  • TABLE 207. EUROPEAN UNION CORD BLOOD BANKING SERVICES MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 208. EUROPEAN UNION CORD BLOOD BANKING SERVICES MARKET SIZE, BY TRANSPLANTATION, 2018-2032 (USD MILLION)
  • TABLE 209. EUROPEAN UNION CORD BLOOD BANKING SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 210. BRICS CORD BLOOD BANKING SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 211. BRICS CORD BLOOD BANKING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 212. BRICS CORD BLOOD BANKING SERVICES MARKET SIZE, BY PROCESSING METHOD, 2018-2032 (USD MILLION)
  • TABLE 213. BRICS CORD BLOOD BANKING SERVICES MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 214. BRICS CORD BLOOD BANKING SERVICES MARKET SIZE, BY STORAGE DURATION, 2018-2032 (USD MILLION)
  • TABLE 215. BRICS CORD BLOOD BANKING SERVICES MARKET SIZE, BY CELL TYPE, 2018-2032 (USD MILLION)
  • TABLE 216. BRICS CORD BLOOD BANKING SERVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 217. BRICS CORD BLOOD BANKING SERVICES MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2032 (USD MILLION)
  • TABLE 218. BRICS CORD BLOOD BANKING SERVICES MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 219. BRICS CORD BLOOD BANKING SERVICES MARKET SIZE, BY TRANSPLANTATION, 2018-2032 (USD MILLION)
  • TABLE 220. BRICS CORD BLOOD BANKING SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 221. G7 CORD BLOOD BANKING SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 222. G7 CORD BLOOD BANKING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 223. G7 CORD BLOOD BANKING SERVICES MARKET SIZE, BY PROCESSING METHOD, 2018-2032 (USD MILLION)
  • TABLE 224. G7 CORD BLOOD BANKING SERVICES MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 225. G7 CORD BLOOD BANKING SERVICES MARKET SIZE, BY STORAGE DURATION, 2018-2032 (USD MILLION)
  • TABLE 226. G7 CORD BLOOD BANKING SERVICES MARKET SIZE, BY CELL TYPE, 2018-2032 (USD MILLION)
  • TABLE 227. G7 CORD BLOOD BANKING SERVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 228. G7 CORD BLOOD BANKING SERVICES MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2032 (USD MILLION)
  • TABLE 229. G7 CORD BLOOD BANKING SERVICES MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 230. G7 CORD BLOOD BANKING SERVICES MARKET SIZE, BY TRANSPLANTATION, 2018-2032 (USD MILLION)
  • TABLE 231. G7 CORD BLOOD BANKING SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 232. NATO CORD BLOOD BANKING SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 233. NATO CORD BLOOD BANKING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 234. NATO CORD BLOOD BANKING SERVICES MARKET SIZE, BY PROCESSING METHOD, 2018-2032 (USD MILLION)
  • TABLE 235. NATO CORD BLOOD BANKING SERVICES MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 236. NATO CORD BLOOD BANKING SERVICES MARKET SIZE, BY STORAGE DURATION, 2018-2032 (USD MILLION)
  • TABLE 237. NATO CORD BLOOD BANKING SERVICES MARKET SIZE, BY CELL TYPE, 2018-2032 (USD MILLION)
  • TABLE 238. NATO CORD BLOOD BANKING SERVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 239. NATO CORD BLOOD BANKING SERVICES MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2032 (USD MILLION)
  • TABLE 240. NATO CORD BLOOD BANKING SERVICES MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 241. NATO CORD BLOOD BANKING SERVICES MARKET SIZE, BY TRANSPLANTATION, 2018-2032 (USD MILLION)
  • TABLE 242. NATO CORD BLOOD BANKING SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 243. GLOBAL CORD BLOOD BANKING SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 244. UNITED STATES CORD BLOOD BANKING SERVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 245. UNITED STATES CORD BLOOD BANKING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 246. UNITED STATES CORD BLOOD BANKING SERVICES MARKET SIZE, BY PROCESSING METHOD, 2018-2032 (USD MILLION)
  • TABLE 247. UNITED STATES CORD BLOOD BANKING SERVICES MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 248. UNITED STATES CORD BLOOD BANKING SERVICES MARKET SIZE, BY STORAGE DURATION, 2018-2032 (USD MILLION)
  • TABLE 249. UNITED STATES CORD BLOOD BANKING SERVICES MARKET SIZE, BY CELL TYPE, 2018-2032 (USD MILLION)
  • TABLE 250. UNITED STATES CORD BLOOD BANKING SERVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 251. UNITED STATES CORD BLOOD BANKING SERVICES MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2032 (USD MILLION)
  • TABLE 252. UNITED STATES CORD BLOOD BANKING SERVICES MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 253. UNITED STATES CORD BLOOD BANKING SERVICES MARKET SIZE, BY TRANSPLANTATION, 2018-2032 (USD MILLION)
  • TABLE 254. UNITED STATES CORD BLOOD BANKING SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 255. CHINA CORD BLOOD BANKING SERVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 256. CHINA CORD BLOOD BANKING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 257. CHINA CORD BLOOD BANKING SERVICES MARKET SIZE, BY PROCESSING METHOD, 2018-2032 (USD MILLION)
  • TABLE 258. CHINA CORD BLOOD BANKING SERVICES MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 259. CHINA CORD BLOOD BANKING SERVICES MARKET SIZE, BY STORAGE DURATION, 2018-2032 (USD MILLION)
  • TABLE 260. CHINA CORD BLOOD BANKING SERVICES MARKET SIZE, BY CELL TYPE, 2018-2032 (USD MILLION)
  • TABLE 261. CHINA CORD BLOOD BANKING SERVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 262. CHINA CORD BLOOD BANKING SERVICES MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2032 (USD MILLION)
  • TABLE 263. CHINA CORD BLOOD BANKING SERVICES MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 264. CHINA CORD BLOOD BANKING SERVICES MARKET SIZE, BY TRANSPLANTATION, 2018-2032 (USD MILLION)
  • TABLE 265. CHINA CORD BLOOD BANKING SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)